Our website uses cookies. By continuing to use this site, you agree to our use of cookies in accordance with this notice and the Terms of Use.
Submit manuscript
Theoretical economics
Journals / Theoretical economics / Issue 7, 2024 / The quality of the production process of antiretroviral therapy drugs as an essential component of the quality of life of patients with HIV in the context of the domestic pharmaceutical market

THE QUALITY OF THE PRODUCTION PROCESS OF ANTIRETROVIRAL THERAPY DRUGS AS AN ESSENTIAL COMPONENT OF THE QUALITY OF LIFE OF PATIENTS WITH HIV IN THE CONTEXT OF THE DOMESTIC PHARMACEUTICAL MARKET The quality of the production process of antiretroviral therapy drugs as an essential component of the quality of life of patients with HIV in the context of the domestic pharmaceutical market

Published in Theoretical economics · Pages 102–120 · Rubric: YOUNG RESEARCHERS
DOI: https://doi.org/10.52957/2221-3260-2024-7-102-121
Received: 19.07.2024 Accepted: 24.07.2024 Published: 06.09.2024
Authors
AL
Aleksandr Ermishin
ORCID
IR
Irina V'yugina
AN
Anastasiya Fomina
ORCID
ABSTRACT
The article presents the results of a comprehensive scientific analysis, including an analysis of the Russian pharmaceutical market for antiretroviral therapy drugs, an analysis of the HIV status of the population in the Russian Federation over the past few years, and an analysis of the production of antiretroviral drugs using the example of «Ritonavir». It is the most commonly used and effective antiretroviral drug used with other drugs to treat HIV. At the present stage of pharmaceutical development, the intrinsic antiviral activity of this drug is rarely used, but it is still widely used as an enhancer for other HIV protease inhibitor drugs. The availability of antiretroviral drugs, their quality and safety will directly depend on the streamlined technological process and the stability of production. The scientific result of the work is that for the first time a comprehensive study was carried out that included 3 components: an analysis of the domestic pharmaceutical market for antiretroviral therapy drugs, the state of HIV infection among the population in Russia, and an analysis of the production of these drugs using the example of «Ritonavir». It is noted that the Russian pharmaceutical market is demonstrating dynamic development: over the past 20 years, market growth has amounted to 11.43 times, or by 2348 billion rubles, over 5 years – 56.89% (or by 933 billion rubles), over the last year – by 11.97% (or 275 billion rubles). In 2022, a significant reduction in the volume of hospital purchases was noted for drugs with a price in the range of 150-500 rubles – by 1.9% (to the level of 5.8%), preference was given to more expensive ones, including drugs active against HIV containing «Ritonavir». An analysis of the state of HIV incidence in Russia showed a decline in the number of detected cases (over the last 7 years – 1.8 times, to the level of 56,003 people), a positive trend in the number of patients receiving antiretroviral therapy was noted – up to 99.3% in the country. In 2022, mortality in Russia from HIV amounted to 15,804 people, which is 1,110 people less than last year (or 6.56%) and amounted to 0.8% of the total number of deaths this year and has been trending downward over the past five years. An analysis of the suitability and efficiency of the «Ritonavir» tableting process at one of the capital’s domestic pharmaceutical enterprises for the critical quality attribute «Height» showed that the process suitability index was 1.075, which indicates its theoretical reproducibility, and the efficiency index was 0.835, which indicates that the process is not centralized, and additional adjustment of the tableting process is necessary, since the risk of obtaining tablets with a large height is high, which, in turn, increases the risk of foil breakthrough at the blister packing stage and will affect the quality and safety of the drug. Ultimately, the quality of life of people living with HIV and undergoing therapy depends on this.
KEYWORDS
analysis of the domestic pharmaceutical market; antiretroviral drugs; HIV infection; morbidity; mortality; manufacturing process; statistical controllability.
Text References
Text
Text (PDF)
Read Download

1. Parsons, S.K. Measuring Quality of Life and Health-Related Quality of Life [Text] / S.K. Parsons, N. Linendoll, C. Schroeder // Palliative Care in Hematologic Malignancies and Serious Blood Disorders, Springer, Cham, 2023. – Pp. 139-151. https://doi.org/10.1007/978-3-031-38058-7_12.

2. Rasporyazhenie Pravitel'stva RF ot 12.10.2019 № 2406-r (red. ot 09.06.2023) «Ob utverzhdenii perechnya zhiznenno neobhodimyh i vazhneyshih lekarstvennyh preparatov, a takzhe perechney lekarstvennyh preparatov dlya medicinskogo primeneniya i minimal'nogo assortimenta lekarstvennyh preparatov, neobhodimyh dlya okazaniya medicinskoy pomoschi» / Konsul'tacionnopravovoy portal «Konsul'tantPlyus» [Elektronnyy resurs]. – Rezhim dostupa: https://www.consultant. ru/document/cons_doc_LAW_335635/.

3. Fomina, A.M. Ocenka kachestva i bezopasnosti acetilsalicilovoy kisloty otechestvennyh proizvoditeley [Tekst] / A.M. Fomina, A.S. Ermishin // Teoreticheskie i prakticheskie aspekty cifrovizacii rossiyskoy ekonomiki: sb. tr. V Mezhdunar. nauch.-prakt. konf. (8 dekabrya 2022 g., Yaroslavl') / pod obsch. red. k.e.n. S.V. Shkiotova, d.e.n. V.A. Gordeeva. – Yaroslavl' : Izd-vo YaGTU, 2022. – S. 367-373.

4. Analiticheskiy otchet «Farmacevticheskiy rynok Rossii. Itogi 2004 g.» / DSM Group [Elektronnyy resurs]. – Rezhim dostupa:https://dsm.ru/upload/iblock/75e/75e48089435f1a1c9dd7d0f1e a266c0d.pdf.

5. Analiticheskiy otchet «Farmacevticheskiy rynok Rossii. Itogi 2020 g.» / DSM Group [Elektronnyy resurs]. – Rezhim dostupa: https://dsm.ru/docs/analytics/2020_Report_rus.pdf.

6. Analiticheskiy otchet «Farmacevticheskiy rynok Rossii. Itogi 2022 g.» / DSM Group [Elektronnyy resurs]. – Rezhim dostupa: https://dsm.ru/docs/analytics/Annual_report_2023_rus.pdf.

7. Social'no-znachimye zabolevaniya naseleniya Rossii v 2021 godu: statisticheskie materialy [Tekst] / E.G. Kotova, O.S. Kobyakova, V.I. Starodubov, G.A. Aleksandrova, N.A. Golubev, D.A. Kucheryavaya, E.V. Ogryzko, A.V. Polikarpov, E.A. Shelepova [i dr.]. – M.: CNIIOIZ Minzdrava Rossii, 2022. – S. 9-15.

8. Social'no-znachimye zabolevaniya naseleniya Rossii v 2022 godu: statisticheskie materialy [Tekst] / E.G. Kotova, O.S. Kobyakova, V.I. Starodubov, G.A. Aleksandrova, N.A. Golubev, D.A. Kucheryavaya, E.V. Ogryzko, A.V. Polikarpov, E.A. Shelepova [i dr.]. – M.: FGBU «CNIIOIZ» Minzdrava Rossii, 2023. – S. 9-15.

9. Estestvennoe dvizhenie naseleniya Rossiyskoy federacii za 2022 god. (Statisticheskiy byulleten') [Tekst]. – M.: Rosstat, 2023. – S. 17.

10. Estestvennoe dvizhenie naseleniya Rossiyskoy federacii za 2018 god. (Statisticheskiy byulleten') [Tekst]. – M.: Rosstat, 2019. – S. 20.

11. GOST R ISO 22514-4-2021 Statisticheskie metody. Upravlenie processami. Chast' 4. Ocenka pokazateley vosproizvodimosti i prigodnosti processa [Tekst]. Vved. 2022-01-01. – M. : FGBU «RST», 2021. – S. 3, 13.

12. Rasporyazhenie ot 06 oktyabrya 2022 g. № 2927-r «O vnesenii izmeneniy v rasporyazhenie Pravitel'stva RF ot 12.10.2019 № 2406-r» / Konsul'tacionno-pravovoy portal «Konsul'tantPlyus» [Elektronnyy resurs]. – Rezhim dostupa: https://www.consultant.ru/document/cons_doc_LAW_428641/ f62ee45faefd8e2a11d6d88941ac66824f848bc2/.

13. Centr peredovyh instrumentov upravleniya kachestvom (Advanced Quality Tools, AQT) [Elektronnyy resurs]. – Rezhim dostupa: https://advanced-quality-tools.ru/.

14. GOST R ISO 7870-2-2015 Statisticheskie metody. Kontrol'nye karty. Chast' 2. Kontrol'nye karty Shuharta [Tekst]. Vved. 2016-12-01. M.: Standartinform, 2019. – S.8-9.

15. Bruguera, A. Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project [Text] / A. Bruguera, L. Egea-Cortés, J. Mesías-Gazmuri, J. Palacio-Vieira et. al. // HIV Medicine, December 2023. https://doi.org/10.1111/hiv.13590

This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
PDF Text JATS XML
The contact persons
Executive editor
Maksim Markin
markinmi@ystu.ru
Chief Editor
Valery Gordeev
vagordeev@rambler.ru
Deputy Editor-in-Chief
Marina Mayorova
mayorovama@ystu.ru
Deputy editor-in-chief
Galina Rodina
galinarodina@mail.ru
5460
downloads
Crossref VAK Antiplagiat Anri Cyberleninka RINC Science Index Open Alex Semantic scholar Scilit Dimensions RCSI
CC
This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Creative Commons
© theoreticaleconomy.ru
Agreement Personal data protection and processing policy Support Powered by Editorum, 2026 Instructions
Login or Create
* Forgot your password?